Laboratorio Teuto Brasileiro, Pfizer deal

Pfizer will acquire a 40% stake in Brazilian generics company Laboratorio Teuto Brasileiro as part of a deal under which Pfizer will gain rights to commercialize Teuto's products in Brazil and other countries under Pfizer's own brands. Products include branded and unbranded generics in areas such as pain and inflammation, cardiovascular, anti-infectives, CNS and respiratory diseases. Teuto also will have rights to commercialize certain Pfizer products under Teuto's own brand in Brazil. ...